Digital Therapeutics Market: By Application (Obesity, Diabetes, Central Nervous System Diseases, Cardio Vascular Disorders, Respiratory Disease, Others), By End User (Healthcare Providers, Payers, Employees, Others), By Geography  

Digital Therapeutics Market size was valued at USD 3.2 billion in 2022 and is expected to grow at a CAGR of 28.8% from 2023-2029. The global digital therapeutics is still at development stage, few market players are present in the market. The advent of new companies and introduction of innovative digital therapies expected to boost the market over the forecast period. Furthermore, market players are collaborating with other companies to provide digital therapy for the patients. Industry trends in the market are evolving, which will aid players in developing successful long-term strategies. Both established and emerging markets have implemented business growth techniques. COVID-19 is an unprecedented worldwide public health crisis that has impacted practically every business, and its long-term repercussions are expected to have an influence on industry growth during the projection period. Our continuous study is enhancing our research approach to guarantee that fundamental COVID-19 concerns and potential solutions are included. The research examines COVID-19 in light of changes in consumer packaging behaviour and demand, purchasing patterns, supply chain re-routing, market dynamics, and government involvement. The revised report considers the influence of COVID-19 on the market and includes insights, analysis, projections, and predictions.

Digital Therapeutics Market Key Developments:

• In March 2017, Sanofi S.A. has collaborated agreement with Voluntis S.A. to deliver digital insulin titration solutions, featuring mobile phone application for type -II Diabetes.
• In November 2017, U.S. FDA has approved Proteus Digital Healths ABILIFY MYCYTE, aripirazole tablet with the sensor enables track the patient’s medications with the help of a wearable patch.